BIOGEN INC. - 8-K Filing
Biogen reports Q3 2026 revenue of $2.8 billion, up 11% YoY, driven by a 49% increase in Growth Portfolio revenue. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $BIIB
Read the full article at SEC EDGAR
Part of the story Curbline Properties Reports Q3 2026 Growth Driven by Asset Acquisitions and Increased Investment Targets (12 articles)